Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP

PHASE3CompletedINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

December 31, 2012

Conditions
Pneumonia
Interventions
DRUG

Levofloxacin

levofloxacin 500 mg,QD,7\~10 days

DRUG

Nemonoxacin

Nemonoxacin 500mg,QD,7\~10 days

Trial Locations (57)

Unknown

Anzhen Hospital,Beijing Capital Medical University, Anzhen

Beijing Union Medical College Hospital, Beijing

General Hospital of PLA Second Artillery, Beijing

Peking University First Hospital, Beijing

Peking University People's Hospital, Beijing

Beijing Chaoyang Hospital, Chaoyang

West China Hospital of Sichuan University,Center for Infection Disease, Chengdu

PLA Third Militrary Medical University,Second Affiliated Hospital, Chongqing

PLA Third Militrary Medical University,Third Affiliated Hospital, Chongqing

The First Affiliated Hospital,Chongqing Medical University, Chongqing

The First Hospital of Fujian Medical University, Fuzhou

People's Hospital of Gansu Province, Gansu

GuangZhou Red Cross Hospital, Guangzhou

Sun Yet-sen Memorial Hospital, Guangzhou

Affilated Hospital of Guilin Medical college, Guilin

Hainan Provincial People's Hospital, Hainan

Hospital Affiliated to Hainan Medical College, Hainan

Hubei General Hospital, Hubei

Taihe Hospital, Hubei

Hunan Provincial People's Hospital, Hunan

Third Xiangya Hospital,Central South University, Hunan

People's Hospital of Jiangxi Province, Jiangxi

Jinan Central Hospital, Jinan

Lanzhou university second hospital, Lanzhou

Shengjing Hospital of China Medical University, Liaoning

Second Affiliated Hospital of Nanchang University, Nanchang

Nanjing Genrak Hospital of Nanjing Millitary Command, Nanjing

Huadong Hospital of Fudan University, Shanghai

Putuo Central Hospital, Shanghai

Shanghai Changzheng Hospital, Shanghai

Shanghai East Hospital in Pudong New Area, Shanghai

Shanghai Sixth People's Hospital, Shanghai

The First Hospital of Shanxi Medical College, Shanxi

PLA General Hospital of Shenyang Military Region, Shenyang

ShenZhen People's Hospital, Shenzhen

Institute of Antibiotics,Huashan Hospital ,Fudan University, Shianghai

Department of Resoiratory Medicine,West China Hospital of Sichuan University, Sichuan

Shuang Ho Hospital, Taipei

The Second Hospital of Wenzhou Medical College, Wenzhou

Wuhan General Hospital of Guangzhou Millitary Command, Wuhan

The First Affiliated Hospital,Xinjiang Medical University, Xinjiang

First Affiliated Hospital,Zhejiang University School of Medicine, Zhejiang

Chia-Yi Christian Hospital, Chiayi City

E-Da Hospital, Kaohsiung City

Kaohsiung hang Gung Memorial Hospital, Kaohsiung City

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

Yuan's General Hospital, Kaohsiung City

ChiMei Medical Hospital-Liuying branch, Liuying

Cheng Ching General Hospital, Taichung

China Medical University Hospital, Taichung

Chung Shan Medical University Hospital, Taichung

Veterans General Hospital-TaiChung, Taichung

Cheng Hsin General Hospital, Taipei

Far-East Memorial Hospital, Taipei

National Taiwan University Hospital, Taipei

Tri-Service General Hospital, Taipei

Veterans General Hospital-Taipei, Taipei

Sponsors
All Listed Sponsors
collaborator

Qualitix Clinical Research Co., Ltd.

INDUSTRY

collaborator

Parexel

INDUSTRY

collaborator

PPD Development, LP

INDUSTRY

lead

TaiGen Biotechnology Co., Ltd.

INDUSTRY